Jain M - Search Results

1

Genetically engineered mucin mouse models for inflammation and cancer.

Joshi S, Kumar S, Bafna S, Rachagani S, Wagner KU, Jain M, Batra SK. Joshi S, et al. Among authors: jain m. Cancer Metastasis Rev. 2015 Dec;34(4):593-609. doi: 10.1007/s10555-015-9549-1. Cancer Metastasis Rev. 2015. PMID: 25634251 Free PMC article. Review.

2

Mucins in protozoan parasites.

Jain M, Karan D, Batra SK, Varshney GC. Jain M, et al. Front Biosci. 2001 Oct 1;6:D1276-83. doi: 10.2741/jain. Front Biosci. 2001. PMID: 11578964 Review.

3

Pharmacokinetics and biodistribution of genetically engineered antibodies.

Batra SK, Jain M, Wittel UA, Chauhan SC, Colcher D. Batra SK, et al. Among authors: jain m. Curr Opin Biotechnol. 2002 Dec;13(6):603-8. doi: 10.1016/s0958-1669(02)00352-x. Curr Opin Biotechnol. 2002. PMID: 12482521 Review.

4

Genetically engineered antibody fragments and PET imaging: a new era of radioimmunodiagnosis.

Jain M, Batra SK. Jain M, et al. J Nucl Med. 2003 Dec;44(12):1970-2. J Nucl Med. 2003. PMID: 14660723 Free article. No abstract available.

5

Generation and characterization of anti-MUC4 monoclonal antibodies reactive with normal and cancer cells in humans.

Moniaux N, Varshney GC, Chauhan SC, Copin MC, Jain M, Wittel UA, Andrianifahanana M, Aubert JP, Batra SK. Moniaux N, et al. Among authors: jain m. J Histochem Cytochem. 2004 Feb;52(2):253-61. doi: 10.1177/002215540405200213. J Histochem Cytochem. 2004. PMID: 14729877

6

Engineering and characterization of a divalent single-chain Fv angiotensin II fusion construct of the monoclonal antibody CC49.

Wittel UA, Jain M, Goel A, Baranowska-Kortylewicz J, Kurizaki T, Chauhan SC, Agrawal DK, Colcher D, Batra SK. Wittel UA, et al. Among authors: jain m. Biochem Biophys Res Commun. 2005 Apr 1;329(1):168-76. doi: 10.1016/j.bbrc.2005.01.101. Biochem Biophys Res Commun. 2005. PMID: 15721289

7

The in vivo characteristics of genetically engineered divalent and tetravalent single-chain antibody constructs.

Wittel UA, Jain M, Goel A, Chauhan SC, Colcher D, Batra SK. Wittel UA, et al. Among authors: jain m. Nucl Med Biol. 2005 Feb;32(2):157-64. doi: 10.1016/j.nucmedbio.2004.11.003. Nucl Med Biol. 2005. PMID: 15721761

8

Pharmacokinetics and biodistribution of 177Lu-labeled multivalent single-chain Fv construct of the pancarcinoma monoclonal antibody CC49.

Chauhan SC, Jain M, Moore ED, Wittel UA, Li J, Gwilt PR, Colcher D, Batra SK. Chauhan SC, et al. Among authors: jain m. Eur J Nucl Med Mol Imaging. 2005 Mar;32(3):264-73. doi: 10.1007/s00259-004-1664-0. Epub 2004 Oct 2. Eur J Nucl Med Mol Imaging. 2005. PMID: 15791435

9

Penetratin improves tumor retention of single-chain antibodies: a novel step toward optimization of radioimmunotherapy of solid tumors.

Jain M, Chauhan SC, Singh AP, Venkatraman G, Colcher D, Batra SK. Jain M, et al. Cancer Res. 2005 Sep 1;65(17):7840-6. doi: 10.1158/0008-5472.CAN-05-0662. Cancer Res. 2005. PMID: 16140953

10

Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125).

Chauhan SC, Singh AP, Ruiz F, Johansson SL, Jain M, Smith LM, Moniaux N, Batra SK. Chauhan SC, et al. Among authors: jain m. Mod Pathol. 2006 Oct;19(10):1386-94. doi: 10.1038/modpathol.3800646. Epub 2006 Jul 28. Mod Pathol. 2006. PMID: 16880776 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,241 results

Search Page